Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ING Groep NV (ING) vs Intuitive Surgical, Inc. (ISRG) Price & Performance

ING Groep NVTrade
Intuitive Surgical, Inc.Trade

Price performance (Past 24H)

Key statistics

ING Groep NV vs Intuitive Surgical, Inc. — how do they compare? ING Groep NV trades at $33.38 (market cap $93.76B), while Intuitive Surgical, Inc. trades at $422.49 (market cap $146.76B). The key difference: Intuitive Surgical, Inc. is the larger of the two by market cap, and ING Groep NV pays a 3.95% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold ING Groep NV for 93 Days and Intuitive Surgical, Inc. for 84 Days on average.

INGISRG
Market Cap
$93.76B$146.76B
Volume
4,620,2202,529,814
Sector
FinancialsHealth
52-Week High
$37.27$592.85
52-Week Low
$23.66$332.02
Typical Hold Time
93 Days84 Days
Enterprise Value
$236.48B$141.54B
Dividend Yield
3.95%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ING Groep NV

ING stock trades at $33.92, down 2.81% today, with a bearish technical outlook despite recent earnings beats. The company shows strong profitability with 28.34% net income margin and 13.49% ROE, supported by management's raised ROE target above 16% for 2027. Recent news highlights strategic focus on organic growth and bolt-on acquisitions while maintaining capital discipline.

While analyst consensus remains strongly bullish with 65% buy ratings, negative cash flow trends and regulatory scrutiny in Australia present near-term risks. The stock's attractive valuation at 12.86 P/E offers potential upside if the company can execute on its growth strategy and improve cash generation.

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $414.52, up 2.41% today, with strong bullish technical signals from moving averages. The company demonstrates robust fundamentals with revenue growth from $6.2B in 2022 to $10.1B in 2025 and net income margin expanding to 28.45%. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.80 surpassing the $2.48 forecast.

ISRG maintains a dominant position in robotic surgery with expanding international growth, though valuation multiples remain elevated with a P/E of 47.64. Analyst consensus is strongly bullish with a $480.78 price target representing 16% upside potential. Key risks include competitive pressures and international market volatility, particularly in China.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ING
100% Buy0% Sell
Avg holding period · 93 Days
ISRG
25% Buy75% Sell
Avg holding period · 84 Days

Top news

Latest headlines on both assets

About ING Groep NV

The merger of the Dutch postal bank and NN Insurance in 1991 created ING. Through a series of further acquisitions ING build up a global footprint. The 2008 financial crisis forced ING to seek government support--a precondition of which was that ING should separate its banking and insurance activities, which saw ING revert to being solely a bank. ING has market- leading banking operations in the Netherlands and Belgium, and a range of digital banks across Europe and Australia. Its global wholesale banking operation is primarily focused on lending.

Read more on ING →

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG →